ISSN: 2095-1264

Journal Home

Journal Guideline

Anti-Tumor Pharmacy Q4 Unclaimed

0 China

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Anti-Tumor Pharmacy is a journal indexed in SJR in Oncology and Pharmaceutical Science with an H index of 1. It has an SJR impact factor of 0,101 and it has a best quartile of Q4. It has an SJR impact factor of 0,101.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q4) Pharmaceutical Science (Q4) Pharmacology (medical) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,101

SJR Impact factor

1

H Index

0

Total Docs (Last Year)

24

Total Docs (3 years)

0

Total Refs

1

Total Cites (3 years)

24

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Experimental Oncology Q4
Journal of Biological Regulators and Homeostatic Agents Q4
Chinese Journal of Oncology Q4
Middle East Journal of Cancer Q4
Acta Haematologica Polonica Q4

Compare this journals

Anti-Tumor Pharmacy Q4 Unclaimed

- €

NPD

- €

Metrics

0,101

1

0

24

0

1

24

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of Anti-Tumor Pharmacy?